EUVIMEDEUVIMED entdecken
Kohortenstudie

The relationship between impaired upper-body function, quality of life and breast cancer-related lymphoedema: results from a prospective, population-based cohort study

Hildegard M Reul-Hirche, Matthew R Dunn, Melanie L Plinsinga, E-Liisa Laakso, Melissa A Troester, Sandra C Hayes

Breast Cancer Research and Treatment · 2026

DOI: 10.1007/s10549-025-07877-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Breast Cancer Research and Treatment, 2026. Verfasst von Hildegard M Reul-Hirche und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences and Social Work, Griffith University, Brisbane, QLD, 4111, Australia. hildegard.reul-hirche@griffithuni.edu.au. Hauptthemen laut MEDLINE: Quality of Life, Breast Neoplasms, Lymphedema, Breast Cancer Lymphedema. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Cancer Institute's National Research Service Award sponsored by the Lineberger Comprehensive Cancer Center at the University of North Carolina ., National Cancer Institute’s National Research Service Award sponsored by the Lineberger Comprehensive Cancer Center at the University of North Carolina ., Cancer Council Queensland Next Generation Cancer Research Fellowship..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To describe upper-body function in women after breast cancer treatment; and to explore the relationship between upper-body function, quality of life and breast cancer- related lymphoedema up to 7-years post-diagnosis. METHODS: This study uses data collected in a prospective, longitudinal, population-based, breast cancer cohort study. The Disability of Arm, Shoulder and Hand questionnaire (short version -QuickDASH), the Functional Assessment of Cancer Therapy-Breast questionnaire (FACT-B) and self-report of a clinical diagnosis were used to assess upper-body function, quality of life and breast cancer-related lymphoedema, respectively, in 2,876 women with invasive breast cancer at three time points: baseline (up to 9 months post-diagnosis), and at 2- and 7-years post-diagnosis. Unadjusted cross-sectional relationships between outcomes of interest were tested at each time point. Unadjusted and adjusted regression analyses were used to explore the potential predictive relationship between upper-body function and lymphoedema. RESULTS: Upper-body impairment was common up to 7-years post-diagnosis with > 60% of women reporting at least mild impairment and 23.8-25.6% reporting moderate to very severe impairment. Impaired upper-body function at baseline assessment was associated with poorer overall quality of life (mean (standard deviation) FACT-B for no versus mild impairment: 77.5 (11.8) versus 70.9 (12.1), p < 0.05) and increased odds of breast cancer-related lymphoedema at 2 and 7 years follow-up (moderate to severe upper-body function impairment at 2- and 7- years post-diagnosis: Odds Ratio (95% Confidence interval) 2.49 (1.57, 3.93) and 2.54 (1.51, 4.26), respectively). CONCLUSION: Future research evaluating whether prospective monitoring of upper-body function and interventions that can address impairment can reduce the risk of breast cancer-related lymphoedema are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeBreast NeoplasmsLymphedemaBreast Cancer LymphedemaHumansFemaleMiddle AgedProspective StudiesAgedSurveys and QuestionnairesAdultUpper ExtremityLongitudinal Studies

Stichwörter der Autor:innen

Breast cancerCohort studyImpairmentLymphoedemaRiskUpper-body function

Autor:innen und Institutionen

  • School of Health Sciences and Social Work, Griffith University, Brisbane, QLD, 4111, Australia. hildegard.reul-hirche@griffithuni.edu.au.
  • Physiotherapy Department, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4029, Australia. hildegard.reul-hirche@griffithuni.edu.au.
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.
  • Australian Centre for Precision Health and Technology, Griffith University, Gold Coast, QLD, 4222, Australia.
  • School of Health Sciences and Social Work, Griffith University, Brisbane, QLD, 4111, Australia.
  • Mater Research Institute, University of Queensland, South Brisbane, QLD, 4101, Australia.

Förderung

  • National Cancer Institute's National Research Service Award sponsored by the Lineberger Comprehensive Cancer Center at the University of North Carolina .
  • National Cancer Institute’s National Research Service Award sponsored by the Lineberger Comprehensive Cancer Center at the University of North Carolina .
  • Cancer Council Queensland Next Generation Cancer Research Fellowship.

Zitieren

APA

Reul-Hirche, H. M., Dunn, M. R., Plinsinga, M. L., Laakso, E. L., Troester, M. A., & Hayes, S. C. (2026). The relationship between impaired upper-body function, quality of life and breast cancer-related lymphoedema: results from a prospective, population-based cohort study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-025-07877-2

Vancouver

Reul-Hirche HM, Dunn MR, Plinsinga ML, Laakso EL, Troester MA, Hayes SC. The relationship between impaired upper-body function, quality of life and breast cancer-related lymphoedema: results from a prospective, population-based cohort study. Breast Cancer Research and Treatment. 2026. doi:10.1007/s10549-025-07877-2

BibTeX
@article{ReulHirche2026,
  author = {Reul-Hirche, Hildegard M and Dunn, Matthew R and Plinsinga, Melanie L and Laakso, E-Liisa and Troester, Melissa A and Hayes, Sandra C},
  title = {The relationship between impaired upper-body function, quality of life and breast cancer-related lymphoedema: results from a prospective, population-based cohort study},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  doi = {10.1007/s10549-025-07877-2}
}
Kostenlos starten →